Logo image of VERU

VERU INC (VERU) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:VERU - US92536C2026 - Common Stock

2.17 USD
-0.04 (-1.81%)
Last: 12/30/2025, 8:00:02 PM
2.17 USD
0 (0%)
After Hours: 12/30/2025, 8:00:02 PM
Fundamental Rating

2

Overall VERU gets a fundamental rating of 2 out of 10. We evaluated VERU against 191 industry peers in the Pharmaceuticals industry. VERU scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. VERU is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

VERU had negative earnings in the past year.
VERU had a negative operating cash flow in the past year.
VERU had negative earnings in 4 of the past 5 years.
In the past 5 years VERU always reported negative operating cash flow.
VERU Yearly Net Income VS EBIT VS OCF VS FCFVERU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20M -40M -60M -80M

1.2 Ratios

Looking at the Return On Assets, with a value of -76.17%, VERU is doing worse than 72.77% of the companies in the same industry.
Looking at the Return On Equity, with a value of -123.97%, VERU is doing worse than 65.44% of the companies in the same industry.
Industry RankSector Rank
ROA -76.17%
ROE -123.97%
ROIC N/A
ROA(3y)-103.45%
ROA(5y)-68.61%
ROE(3y)-231.35%
ROE(5y)-150.44%
ROIC(3y)N/A
ROIC(5y)N/A
VERU Yearly ROA, ROE, ROICVERU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300 -400

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for VERU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VERU Yearly Profit, Operating, Gross MarginsVERU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

More info and screens

6

2. Health

2.1 Basic Checks

VERU does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for VERU remains at a similar level compared to 1 year ago.
The number of shares outstanding for VERU has been increased compared to 5 years ago.
There is no outstanding debt for VERU. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VERU Yearly Shares OutstandingVERU Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M
VERU Yearly Total Debt VS Total AssetsVERU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -16.71, we must say that VERU is in the distress zone and has some risk of bankruptcy.
VERU's Altman-Z score of -16.71 is on the low side compared to the rest of the industry. VERU is outperformed by 81.15% of its industry peers.
There is no outstanding debt for VERU. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -16.71
ROIC/WACCN/A
WACC9.4%
VERU Yearly LT Debt VS Equity VS FCFVERU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 2.43 indicates that VERU has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.43, VERU is in line with its industry, outperforming 45.03% of the companies in the same industry.
A Quick Ratio of 2.43 indicates that VERU has no problem at all paying its short term obligations.
VERU has a Quick ratio (2.43) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.43
Quick Ratio 2.43
VERU Yearly Current Assets VS Current LiabilitesVERU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 46.43% over the past year.
The Revenue for VERU has decreased by -100.00% in the past year. This is quite bad
EPS 1Y (TTM)46.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%116.67%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

VERU is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.62% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-20.36%
EPS Next 2Y5%
EPS Next 3Y18.24%
EPS Next 5Y27.62%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VERU Yearly Revenue VS EstimatesVERU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2028 2029 2030 2031 100M 200M 300M 400M 500M
VERU Yearly EPS VS EstimatesVERU Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -2 -4 -6 -8 -10

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

VERU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year VERU is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VERU Price Earnings VS Forward Price EarningsVERU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VERU Per share dataVERU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

VERU's earnings are expected to grow with 18.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5%
EPS Next 3Y18.24%

More info and screens

0

5. Dividend

5.1 Amount

VERU does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

VERU INC

NASDAQ:VERU (12/30/2025, 8:00:02 PM)

After market: 2.17 0 (0%)

2.17

-0.04 (-1.81%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)12-17 2025-12-17/bmo
Earnings (Next)02-11 2026-02-11
Inst Owners24.32%
Inst Owner Change-86.96%
Ins Owners10.7%
Ins Owner Change0%
Market Cap31.81M
Revenue(TTM)N/A
Net Income(TTM)-22.73M
Analysts82
Price Target22.95 (957.6%)
Short Float %5.17%
Short Ratio3.82
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)65.58%
Min EPS beat(2)8.08%
Max EPS beat(2)123.07%
EPS beat(4)4
Avg EPS beat(4)43.01%
Min EPS beat(4)8.08%
Max EPS beat(4)123.07%
EPS beat(8)6
Avg EPS beat(8)21.21%
EPS beat(12)8
Avg EPS beat(12)16.35%
EPS beat(16)9
Avg EPS beat(16)4.79%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.88%
PT rev (3m)5.88%
EPS NQ rev (1m)4.43%
EPS NQ rev (3m)4.43%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.74
P/tB 2.78
EV/EBITDA N/A
EPS(TTM)-1.5
EYN/A
EPS(NY)-1.81
Fwd EYN/A
FCF(TTM)-1.49
FCFYN/A
OCF(TTM)-1.48
OCFYN/A
SpS0
BVpS1.25
TBVpS0.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -76.17%
ROE -123.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-103.45%
ROA(5y)-68.61%
ROE(3y)-231.35%
ROE(5y)-150.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 59.02%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.43
Quick Ratio 2.43
Altman-Z -16.71
F-Score3
WACC9.4%
ROIC/WACCN/A
Cap/Depr(3y)217.76%
Cap/Depr(5y)171.53%
Cap/Sales(3y)2.29%
Cap/Sales(5y)1.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)46.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%116.67%
EPS Next Y-20.36%
EPS Next 2Y5%
EPS Next 3Y18.24%
EPS Next 5Y27.62%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y6.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y75.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y75.36%
OCF growth 3YN/A
OCF growth 5YN/A

VERU INC / VERU FAQ

Can you provide the ChartMill fundamental rating for VERU INC?

ChartMill assigns a fundamental rating of 2 / 10 to VERU.


What is the valuation status for VERU stock?

ChartMill assigns a valuation rating of 0 / 10 to VERU INC (VERU). This can be considered as Overvalued.


What is the profitability of VERU stock?

VERU INC (VERU) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for VERU stock?

The Earnings per Share (EPS) of VERU INC (VERU) is expected to decline by -20.36% in the next year.